From Medscape Pulmonary Medicine

Coverage from the

European Respiratory Society (ERS) International Congress 2018

September 15 - 19, 2018; Paris, France

September 15 - 19, 2018 Paris, France
  • ERS 2018 First-in-Class COPD Drug Eases Symptoms An inhaled PDE3/4 inhibitor could serve as an add-on to standard treatments for patients with stubborn symptoms and exacerbations of chronic obstructive pulmonary disease, investigators report.

Conference News

Popular News from ERS 2017

Medscape Pulmonary Medicine© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Previous Coverage